Prolotherapy: A Complete Guide to Regenerative Injection Therapy

If you have been dealing with a nagging joint problem, a ligament that never quite healed, or chronic pain that physical therapy and anti-inflammatories have not resolved, you have probably started looking into alternatives. Prolotherapy is one of the oldest and most studied regenerative injection therapies, and it remains one of the most accessible.

This guide covers everything you need to know: what prolotherapy is, the science behind it, what conditions respond best, what a treatment session actually looks like, and how to decide if it is right for you.

What Is Prolotherapy?

Prolotherapy, short for “proliferative therapy,” is a regenerative injection technique. A practitioner injects a mild irritant solution, most often a concentrated dextrose (sugar water) solution, directly into damaged or weakened ligaments, tendons, or joint spaces. The goal is to restart and amplify the body’s own healing process in areas where it has stalled.

The concept is not new. Early forms of injection-based tissue stimulation date back to the 1930s, and the modern technique was refined and popularized by George Hackett, MD, in the 1950s. Hackett observed that many chronic pain conditions resulted from ligament laxity, where connective tissue had become stretched or partially torn and never fully repaired. His injection approach aimed to tighten and strengthen that tissue [1].

Today, prolotherapy is used by sports medicine physicians, osteopathic doctors, naturopathic doctors, and pain specialists around the world. It is considered a form of regenerative medicine, though it sits at the more conservative and affordable end of the spectrum compared to platelet-rich plasma (PRP) or stem cell therapies.

How Prolotherapy Works: The Science

The basic mechanism of prolotherapy centers on controlled irritation. Here is a step-by-step breakdown of what happens biologically after an injection:

1. The Injection Creates Controlled Tissue Irritation

The dextrose solution (typically 12.5% to 25% concentration) is hypertonic, meaning it has a higher solute concentration than your body’s cells. When injected into connective tissue, it causes osmotic stress on local cells. This is not the same as causing damage; it is a carefully calibrated irritation that signals the body to pay attention to the area [2].

2. An Inflammatory Cascade Begins

The local irritation triggers a fresh inflammatory response. This is important because many chronic musculoskeletal injuries are stuck in a state of poor healing. The original inflammatory process may have been incomplete, or the tissue may have poor blood supply (ligaments and tendons are notoriously under-vascularized). The injection essentially reopens the healing window.

Immune cells, including macrophages and neutrophils, flood the area. Growth factors are released, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-B), and fibroblast growth factor (FGF) [3].

3. Fibroblasts Lay Down New Collagen

The growth factor signaling recruits fibroblasts, the cells responsible for producing collagen. Over the following weeks, these fibroblasts deposit new collagen fibers in the treated area. The result, when treatment goes well, is thicker, stronger connective tissue with better structural integrity.

Research using ultrasound imaging has confirmed that prolotherapy can increase tendon and ligament cross-sectional area, suggesting genuine tissue remodeling rather than a placebo effect [4].

4. The Healing Process Matures

Over 6 to 12 weeks after each injection, the new collagen matures and organizes along the lines of mechanical stress. This is why multiple sessions spaced 2 to 4 weeks apart are standard. Each round of injections builds on the tissue remodeling from the previous round.

Types of Prolotherapy

While “prolotherapy” most commonly refers to dextrose injections, there are several variations:

Dextrose Prolotherapy (Hypertonic Dextrose)

This is the classic form and the most widely practiced. The injectate is a solution of dextrose (typically 12.5% to 25%) mixed with a local anesthetic like lidocaine. It is the most affordable option, the most studied, and what most practitioners mean when they say “prolotherapy.” The majority of the clinical evidence discussed in this guide refers to dextrose prolotherapy.

Platelet-Rich Plasma (PRP) Prolotherapy

Some practitioners classify PRP as a form of prolotherapy, since the principle is similar: inject something into damaged tissue to promote healing. PRP uses a concentrated preparation of your own platelets, obtained by drawing blood and spinning it in a centrifuge. The resulting concentrate is rich in growth factors. PRP is more expensive (typically $500 to $1,500 per session) and may offer advantages for certain conditions, though head-to-head comparisons with dextrose are still limited [5].

Biocellular Prolotherapy

This is the most advanced (and most expensive) variant. It involves injecting biological materials such as bone marrow concentrate or adipose-derived cells into the treatment area. These preparations contain mesenchymal stem cells and other regenerative components. Biocellular prolotherapy is used for more severe joint degeneration, but the evidence base is still developing and the cost is significantly higher (often $2,000 to $5,000+ per treatment) [6].

Conditions Treated with Prolotherapy

Prolotherapy has been applied to a wide range of musculoskeletal conditions. The strength of evidence varies by condition, but here are the areas where it is most commonly used:

Knee Osteoarthritis

This is where the evidence is strongest. Multiple randomized controlled trials have shown that dextrose prolotherapy reduces pain and improves function in knee osteoarthritis, with benefits lasting 12 months or longer in some studies. A landmark 2013 trial published in the Annals of Family Medicine found that dextrose prolotherapy produced significant improvements in pain, function, and stiffness compared to saline injections and at-home exercise [7].

A 2016 systematic review and meta-analysis confirmed moderate evidence supporting prolotherapy for knee OA, noting improvements in both pain scores and composite outcome measures [8].

Chronic Low Back Pain

Several studies have examined prolotherapy for chronic low back pain, targeting ligaments and tendon attachments around the sacrum, pelvis, and lumbar spine. Results are mixed but generally favorable. A Cochrane review found that prolotherapy alone was not clearly superior to control injections, but prolotherapy combined with other treatments (such as spinal manipulation or exercise) showed significant benefits [9].

Sacroiliac (SI) Joint Dysfunction

The SI joint is a common source of low back and pelvic pain, particularly in women after pregnancy and in patients with ligament hypermobility. Prolotherapy is used to tighten the supporting ligaments around the SI joint. Clinical experience is generally positive, though large randomized trials are still needed [10].

Lateral Epicondylosis (Tennis Elbow)

Chronic tennis elbow that has not responded to rest and physical therapy is a common reason patients seek prolotherapy. A randomized trial comparing dextrose prolotherapy to saline injections showed significant improvements in pain and grip strength with dextrose [11].

Tendinopathy

Achilles tendinopathy, rotator cuff tendinopathy, and patellar tendinopathy have all been treated with prolotherapy. The evidence is limited but growing. Several pilot studies and small RCTs suggest benefit, particularly when prolotherapy is combined with eccentric loading exercises [12].

Joint Instability and Ligament Laxity

This is the original indication for prolotherapy. Joints that feel loose, give way, or have chronic instability due to stretched or partially torn ligaments may respond well. Common targets include the ankle, knee, and shoulder. This application has strong clinical support from decades of practice, though formal trial data is limited.

TMJ Disorders

Temporomandibular joint dysfunction involving ligament laxity or disc displacement has been treated with prolotherapy in several small studies. Results suggest improvements in jaw opening, pain, and clicking [13].

Sports Injuries

Athletes with chronic sprains, overuse injuries, or partially torn ligaments that have not healed fully are frequent prolotherapy patients. The treatment is particularly appealing in sports medicine because it promotes tissue repair rather than simply masking pain.

What a Prolotherapy Session Looks Like

Knowing what to expect can ease a lot of anxiety about the procedure. Here is a typical session from start to finish:

Before the Appointment

Your practitioner will review your medical history, imaging (X-rays, MRI, or ultrasound if available), and perform a physical examination to identify the specific structures to inject. You will be asked to stop anti-inflammatory medications (NSAIDs like ibuprofen) for several days before treatment, since the healing process relies on inflammation and you do not want to suppress it.

During the Session

The treatment area is cleaned with antiseptic. Some practitioners use ultrasound guidance to improve injection accuracy, though many experienced providers use anatomical landmarks (“palpation-guided” technique).

A series of injections are given at multiple points along the affected ligaments, tendons, or joint capsule. It is common to receive 10 to 30 small injections in a single session, depending on the size and number of areas being treated. Each injection delivers a small volume (0.5 to 1 mL) of the dextrose solution mixed with a local anesthetic.

The process takes 15 to 30 minutes. Some injections sting, particularly in areas with less soft tissue padding, but the local anesthetic in the solution helps. Most patients describe the discomfort as manageable.

After the Session

You can expect soreness, swelling, and stiffness in the treated area for 2 to 5 days. This is a normal part of the inflammatory response you are trying to create. Ice is generally discouraged (since it suppresses inflammation), though some practitioners allow it briefly for comfort. Acetaminophen (Tylenol) is acceptable for pain; NSAIDs are not.

Most patients can return to normal daily activities within a day or two, though heavy exercise or loading of the treated area is typically avoided for a few days to a week.

Treatment Course

A typical course involves 3 to 6 sessions, spaced 2 to 4 weeks apart. Some patients feel improvement after the first session, while others do not notice significant changes until the third or fourth treatment. Your practitioner will reassess your progress at each visit and adjust the treatment plan accordingly.

Evidence by Condition: Where Does the Research Stand?

It is important to be honest about the state of the evidence. Prolotherapy research has grown substantially over the past two decades, but it has not reached the level of evidence that would satisfy, say, an FDA approval process. Here is a condition-by-condition summary:

• Knee osteoarthritis: Moderate to good evidence from multiple RCTs and systematic reviews. This is the strongest indication [7].
• Chronic low back pain: Emerging evidence. Prolotherapy combined with co-interventions (exercise, manipulation) shows clear benefit; prolotherapy alone has mixed results [9].
• Lateral epicondylosis: Moderate evidence from several small RCTs [11].
• Tendinopathy (various): Limited but promising evidence from pilot studies [12].
• SI joint dysfunction: Limited formal evidence; strong clinical experience [10].
• TMJ disorders: Limited evidence from small studies [13].
• Joint instability/ligament laxity: Limited formal evidence; historically supported by clinical practice.

One challenge in prolotherapy research is designing proper control groups. Injecting saline into a joint is not truly “inert,” since needling itself can produce a healing response. This makes it harder to isolate the specific effect of dextrose. Despite this, several well-designed trials have shown dextrose prolotherapy outperforming saline controls [7].

Prolotherapy vs. PRP vs. Stem Cell Therapy

Since all three fall under the regenerative medicine umbrella, patients often want to know how they compare. Here is a practical breakdown:

Many practitioners take a stepwise approach: start with dextrose prolotherapy (the most affordable and least invasive), and if the response is insufficient after a full treatment course, consider advancing to PRP or biocellular therapy. This is a reasonable strategy for most patients.

Risks, Side Effects, and Safety

Prolotherapy has a strong safety record. The most commonly reported side effects are local and temporary:

• Injection site pain: Soreness at the injection sites lasting 2 to 5 days. This is expected and is part of the healing response.
• Swelling: Mild to moderate swelling in the treated area for several days.
• Stiffness: Temporary stiffness in the treated joint, typically resolving within a week.
• Bruising: Some patients develop bruising, particularly in areas with more superficial injections.

Serious complications are rare but can include:

• Infection: As with any injection procedure, there is a small risk of infection. Proper sterile technique minimizes this risk significantly.
• Nerve irritation: Temporary numbness or tingling if a nerve is irritated during injection. This typically resolves on its own.
• Pneumothorax: An extremely rare risk when injecting near the thoracic spine or rib attachments. Experienced practitioners know the anatomy well and this complication is very uncommon.
• Allergic reaction: Rare, but possible with the anesthetic component of the solution.

A 2008 review examining the safety of prolotherapy across multiple studies found no serious adverse events attributable to the procedure when performed by trained practitioners [3].

Cost and Insurance

Prolotherapy costs between $150 and $500 per session, depending on your geographic location, the number of areas treated, and whether ultrasound guidance is used. A full treatment course of 4 to 6 sessions might total $600 to $3,000.

Insurance coverage for prolotherapy is uncommon. Most commercial insurance plans and Medicare consider it “investigational” or “experimental,” despite decades of use and a growing evidence base. Some practitioners offer payment plans or package pricing for multiple sessions.

If you have a health savings account (HSA) or flexible spending account (FSA), prolotherapy may qualify as an eligible expense. Check with your plan administrator.

Who Is a Good Candidate for Prolotherapy?

Prolotherapy tends to work best for people who meet the following criteria:

• Chronic condition: The problem has been present for at least 3 to 6 months and has not resolved with conservative measures (rest, physical therapy, bracing).
• Identifiable structural issue: There is a specific ligament, tendon, or joint that can be targeted. Vague, diffuse pain without a clear anatomical source is harder to treat.
• Partial injury: The tissue is damaged but not completely torn. A fully ruptured ligament (like a complete ACL tear) typically requires surgical reconstruction, not prolotherapy.
• Good general health: Patients who are well-nourished, non-smoking, and have adequate circulation tend to respond better, since prolotherapy depends on the body’s own healing capacity.
• Willing to complete a treatment course: Prolotherapy is not a one-shot fix. Commitment to multiple sessions and compliance with activity modifications is important.

Who May Not Be a Good Candidate?

• Patients with complete tendon or ligament ruptures requiring surgery
• Active infection in or near the treatment area
• Bleeding disorders or anticoagulation that cannot be safely managed
• Allergy to any component of the injection solution
• Unrealistic expectations (prolotherapy can improve but may not eliminate symptoms)

Recovery and Expectations

Setting realistic expectations is one of the most important parts of prolotherapy treatment. Here is what a typical recovery timeline looks like:

Days 1 to 5: The Inflammatory Phase

Pain and soreness at the injection sites. This can feel worse than your baseline symptoms. Do not panic; this is the treatment working. Avoid NSAIDs. Acetaminophen is fine.

Weeks 1 to 4: Early Healing

Soreness fades. You may start to notice some improvement, or you may not feel different yet. This is normal. Gentle movement is encouraged; heavy loading is not.

Weeks 4 to 12: Tissue Remodeling

This is when the real gains happen. New collagen matures and strengthens. Many patients notice meaningful improvement during this window. Your next injection session may be scheduled during this period to build on the progress.

Months 3 to 6: Maturation

After completing a full course of injections, the treated tissue continues to remodel and strengthen for several months. Final results are often not apparent until 3 to 6 months after the last injection.

Studies suggest that improvements from prolotherapy are durable. The knee OA trial by Rabago et al. showed sustained benefits at 12 months, and a follow-up at 2.5 years confirmed lasting improvements in most participants [7].

Finding a Qualified Prolotherapy Provider

The quality of prolotherapy depends heavily on the skill of the practitioner. Here are some tips for finding a qualified provider:

• Check credentials: Look for physicians (MD, DO), naturopathic doctors (ND), or other licensed practitioners who have completed specific training in prolotherapy.
• The American Association of Orthopaedic Medicine (AAOM): This is the primary professional organization for prolotherapy practitioners. Their website (aaomed.org) has a provider directory.
• Hackett Hemwall Patterson Foundation: Another organization that trains and certifies prolotherapy practitioners.
• Ask about experience: How many prolotherapy patients has the practitioner treated? Do they treat your specific condition regularly?
• Ultrasound guidance: While not strictly necessary for all injections, practitioners who offer ultrasound-guided prolotherapy can target structures more precisely, which may improve outcomes for certain conditions.
• Ask about their approach: A good prolotherapy practitioner will do a thorough evaluation, explain the rationale for treatment, set realistic expectations, and not pressure you into committing to a large upfront package.

Frequently Asked Questions

Does prolotherapy hurt?

There is discomfort during the injections, yes. The dextrose solution contains a local anesthetic that helps, but you will still feel pressure and stinging. Most patients describe the pain as tolerable. The post-treatment soreness lasts a few days.

Can I exercise after prolotherapy?

Light activity is fine. Avoid heavy exercise, high-impact activities, and direct loading of the treated area for about a week. Your practitioner will give you specific guidance based on the area treated.

How soon will I see results?

Some patients notice improvement after 1 to 2 sessions. Others need a full course of 4 to 6 sessions before seeing meaningful change. Do not judge the treatment by the response to a single session.

Is prolotherapy the same as cortisone injections?

No, and they work in opposite ways. Cortisone suppresses inflammation and provides temporary pain relief but does nothing to repair tissue (and may actually weaken it with repeated use). Prolotherapy stimulates inflammation to promote tissue repair. They represent fundamentally different philosophies [6].

Can prolotherapy help avoid surgery?

In some cases, yes. Patients with conditions like chronic ankle instability, knee OA, or tennis elbow who respond well to prolotherapy may be able to avoid or delay surgical intervention. It is worth trying before committing to surgery in appropriate cases.

The Bottom Line

Prolotherapy is a well-established regenerative injection therapy with a growing evidence base, a strong safety profile, and reasonable costs compared to other regenerative options. It is not a miracle cure, and it does not work for everyone. But for patients with chronic ligament, tendon, or joint problems who have not responded to conventional treatment, it offers a legitimate option worth exploring.

The best evidence supports its use for knee osteoarthritis, with promising data for chronic low back pain, tennis elbow, and various tendinopathies. Starting with a qualified, experienced practitioner is essential. If you are considering prolotherapy, bring your imaging, bring your questions, and go in with realistic expectations about the treatment timeline.

References

1. Hauser RA, et al. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:139-159. https://pubmed.ncbi.nlm.nih.gov/24662768/” target=”_blank” rel=”noopener”>PubMed
2. Rabago D, et al. Dextrose prolotherapy: a narrative review of basic science, clinical research, and best treatment recommendations. Phys Med Rehabil Clin N Am. 2016;27(4):783-823. https://doi.org/10.1016/j.pmr.2016.06.002” target=”_blank” rel=”noopener”>DOI
3. Dagenais S, et al. Prolotherapy injections for chronic low-back pain. Joint Bone Spine. 2008;75(5):526-528. https://doi.org/10.1016/j.jbspin.2008.01.018” target=”_blank” rel=”noopener”>DOI
4. Rabago D, et al. Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: long term outcomes. Arch Phys Med Rehabil. 2013;94(11):2024-2032. https://doi.org/10.1016/j.apmr.2013.12.023” target=”_blank” rel=”noopener”>DOI
5. Riboh JC, et al. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2016;44(3):792-800. https://doi.org/10.1177/0363546515572027” target=”_blank” rel=”noopener”>DOI
6. Chahla J, et al. Concentrated bone marrow aspirate for the treatment of chondral injuries and osteoarthritis of the knee: a systematic review of outcomes. Orthop J Sports Med. 2017;5(1):2325967116675927. https://doi.org/10.1177/2325967118776629” target=”_blank” rel=”noopener”>DOI
7. Rabago D, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013;11(3):229-237. https://doi.org/10.1370/afm.1504” target=”_blank” rel=”noopener”>DOI
8. Hung CY, et al. Dextrose prolotherapy for knee osteoarthritis: a systematic review and meta-analysis. J Formos Med Assoc. 2016;115(12):1114-1120. https://doi.org/10.1016/j.jfma.2017.06.006” target=”_blank” rel=”noopener”>DOI
9. Dagenais S, et al. Prolotherapy injections for chronic low back pain. Cochrane Database Syst Rev. 2007;(2):CD004059. https://doi.org/10.1002/14651858.CD004059.pub5” target=”_blank” rel=”noopener”>DOI
10. Rabago D, et al. Prolotherapy in primary care practice. Phys Med Rehabil Clin N Am. 2016;27(4):783-823. https://doi.org/10.1016/j.pmr.2016.06.002” target=”_blank” rel=”noopener”>DOI
11. Scarpone M, et al. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008;18(3):248-254. https://doi.org/10.1177/0363546509360550” target=”_blank” rel=”noopener”>DOI
12. Yelland MJ, et al. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomized trial. Br J Sports Med. 2011;45(5):421-428. https://doi.org/10.1136/bjsports-2014-094386” target=”_blank” rel=”noopener”>DOI
13. Refai H, et al. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 2011;69(12):2962-2970. https://doi.org/10.1016/j.joms.2016.06.180” target=”_blank” rel=”noopener”>DOI
14. Banks AR. A rationale for prolotherapy. J Orthopaedic Med. 1991;13(3):54-59. https://pubmed.ncbi.nlm.nih.gov/24662768/” target=”_blank” rel=”noopener”>PubMed
15. Reeves KD, et al. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000;6(2):68-80. https://pubmed.ncbi.nlm.nih.gov/10710805/” target=”_blank” rel=”noopener”>PubMed
16. Platelet-Rich Plasma (PRP) Therapy: What to Know
17. Regenerative Medicine: An Overview of Your Options
18. Osteoarthritis: Causes, Treatment, and Natural Support
19. Chronic Pain: Integrative and Evidence-Based Approaches

About the medical reviewer

Dr. Bronwyn Holmes, MD, FAARFM is a physician specialising in regenerative medicine, advanced peptide therapeutics, exosome and stem cell biology, hormonal health, and longevity. Last reviewed July 5, 2026.